Recent News

• 05.14.2025 - DarioHealth Reports First Quarter 2025 Financial and Operating Results
• 05.08.2025 - Dario's Digital Health Solution Demonstrates Effectiveness in New Research Examining Flu Vaccination Awareness in High-Risk Populations
• 05.01.2025 - DarioHealth Closes Strategic Refinancing of Existing Debt Facility of up to $50 Million to Provide Additional Operational Flexibility and Support Growth Initiatives
• 04.21.2025 - DarioHealth Announces CFO Transition
• 04.17.2025 - DarioHealth Collaborates with Leading National Benefit Plan Administrator to Offer Cardiometabolic Solution including a GLP-1 Support Program to Employers
• 03.10.2025 - DarioHealth Reports Fourth Quarter and Full year 2024 Financial and Operating Results
• 03.07.2025 - Dario Expands Behavioral Health Offerings to Include a Provider Network Through Strategic Arrangement with Rula
• 03.05.2025 - Dario Signs First Healthcare System as Employer Contract, Expanding Market Presence and Recurring Revenue Growth
• 03.04.2025 - DarioHealth to Report Fourth Quarter and Full Year 2024 Results on Monday, March 10, 2025

Recent Filings

• 05.13.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.06.2025 - 8-K Current report
• 04.28.2025 - 8-K Current report
• 04.21.2025 - 8-K Current report
• 03.19.2025 - 8-K Current report
• 03.14.2025 - 8-K Current report
• 03.10.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.10.2025 - DEF 14A Other definitive proxy statements
• 03.07.2025 - 3 Initial statement of beneficial ownership of securities
• 03.06.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors